These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33861588)

  • 21. Development of anti-chloro
    Lokeshwaran K; Hemadou A; Jayaprakash NS; Prasanna RR; Jacobin-Valat MJ; Dieryck W; Joucla G; Vijayalakshmi MA; Clofent-Sanchez G; Santarelli X; Venkataraman K
    J Immunol Methods; 2019 Nov; 474():112637. PubMed ID: 31386835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities.
    Peng DQ; Wu Z; Brubaker G; Zheng L; Settle M; Gross E; Kinter M; Hazen SL; Smith JD
    J Biol Chem; 2005 Oct; 280(40):33775-84. PubMed ID: 16091367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle.
    Undurti A; Huang Y; Lupica JA; Smith JD; DiDonato JA; Hazen SL
    J Biol Chem; 2009 Nov; 284(45):30825-35. PubMed ID: 19726691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.
    Cho KH; Kim JR
    Exp Mol Med; 2009 Jun; 41(6):417-28. PubMed ID: 19322022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I.
    Chan GK; Witkowski A; Gantz DL; Zhang TO; Zanni MT; Jayaraman S; Cavigiolio G
    J Biol Chem; 2015 Apr; 290(17):10958-71. PubMed ID: 25759391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.
    Shao B; Cavigiolio G; Brot N; Oda MN; Heinecke JW
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12224-9. PubMed ID: 18719109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of myeloperoxidase oxidation and
    Kameda T; Horiuchi Y; Shimano S; Yano K; Lai SJ; Ichimura N; Tohda S; Kurihara Y; Tozuka M; Ohkawa R
    Biol Chem; 2022 Feb; 403(3):265-277. PubMed ID: 34448387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
    Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta.
    Battle S; Gogonea V; Willard B; Wang Z; Fu X; Huang Y; Graham LM; Cameron SJ; DiDonato JA; Crabb JW; Hazen SL
    J Biol Chem; 2022 Apr; 298(4):101832. PubMed ID: 35304099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I.
    Hossain MA; Ngeth S; Chan T; Oda MN; Francis GA
    BMC Biochem; 2012 Jan; 13():1. PubMed ID: 22248050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of novel truncated apolipoprotein A-I in human high-density lipoprotein generated by sequential treatment with myeloperoxidase and chymase.
    Lai SJ; Kameda T; Morita M; Yamagata Y; Nishizaka K; Horiuchi Y; Kobayashi Y; Usami Y; Liu JJ; Kasama T; Tozuka M; Ohkawa R
    Biochimie; 2024 Mar; 218():34-45. PubMed ID: 37774825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.
    Malle E; Marsche G; Panzenboeck U; Sattler W
    Arch Biochem Biophys; 2006 Jan; 445(2):245-55. PubMed ID: 16171772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.
    Cavigiolio G; Geier EG; Shao B; Heinecke JW; Oda MN
    J Biol Chem; 2010 Jun; 285(24):18847-57. PubMed ID: 20385548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.
    Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G
    FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced atheroprotection and lesion remodelling by targeting the foam cell and increasing plasma cholesterol acceptors.
    Son SH; Goo YH; Choi M; Saha PK; Oka K; Chan LC; Paul A
    Cardiovasc Res; 2016 Feb; 109(2):294-304. PubMed ID: 26487692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.
    Sorci-Thomas MG; Zabalawi M; Bharadwaj MS; Wilhelm AJ; Owen JS; Asztalos BF; Bhat S; Thomas MJ
    Biochim Biophys Acta; 2012 Mar; 1821(3):502-12. PubMed ID: 21944998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
    Shao B; Pennathur S; Pagani I; Oda MN; Witztum JL; Oram JF; Heinecke JW
    J Biol Chem; 2010 Jun; 285(24):18473-84. PubMed ID: 20378541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
    Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A
    Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein.
    Kameda T; Ohkawa R; Yano K; Usami Y; Miyazaki A; Matsuda K; Kawasaki K; Sugano M; Kubota T; Tozuka M
    J Lipids; 2015; 2015():592594. PubMed ID: 26257958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein carbamylation renders high-density lipoprotein dysfunctional.
    Holzer M; Gauster M; Pfeifer T; Wadsack C; Fauler G; Stiegler P; Koefeler H; Beubler E; Schuligoi R; Heinemann A; Marsche G
    Antioxid Redox Signal; 2011 Jun; 14(12):2337-46. PubMed ID: 21235354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.